A 3D structure model of integrin α4β1 complex: I. Construction of a homology model of β1 and ligand binding analysis

Biophysical Journal

Volumn 82, Issue 1, 2002, Pages 447-457

  You, Tony J ^a   Maxwell, David S ^a   Kogan, Timothy P ^a   Chen, Qi ^b   Li, Jian ^a   Kassir, Jamal ^a   Holland, George W ^a   Dixon, Richard A F ^a  

^a TEXAS BIOTECHNOLOGY CORPORATION   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTEGRIN; BETA1 INTEGRIN; CELL ADHESION MOLECULE; DOCKING PROTEIN; FIBRONECTIN; MAGNESIUM;

ARTICLE; BINDING SITE; DISEASE COURSE; MODEL; PHARMACOPHORE; PROTEIN BINDING; SIGNAL TRANSDUCTION;

EID: 0036219943     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3495(02)75409-X     Document Type: Article

References (33)

1. Inhibitors of integrin alpha 4 betal (VLA-4)
2. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs
3. The protein information resource (PIR)
4. Identification of ligand binding sites on integrin alpha4beta1 through chemical cross-linking
5. The molecular structure of cell adhesion molecules
6. Protein structure prediction: Implications for the biologist
7. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site
8. Crystal structure of the I domain from integrin alpha2beta1
9. Mutational analysis of MAdCAM-1/alpha4 beta7 interactions reveals significant binding determinants in both the first and second immunoglobulin domains
10. Integrin-ligand interactions: A year in review
11. Novel and highly potent and selective VLA-4 antagonists
12. Integrins and health
13. Critical amino acid residues for ligand binding are clustered in a predicted beta-turn of the third N-terminal repeat in the integrin alpha 4 and alpha 5 subunits
14. Potent alpha 4 beta 1 peptide antagonists as potential anti-inflammatory agents
15. Identification of putative ligand-binding sites of the integrin alpha 4 beta 1 (VLA-4, cd49d/CD29)
16. Selective, tight-binding inhibitors of integrin alpha4beta1 that inhibit allergic airway responses
17. PROCHECK: A program to check the stereochemical quality of protein structures
18. Two conformations of the integrin A-domain (I-domain): A pathway for activation?
19. Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/CD18)
20. Integrin-mediated cell adhesion: The extracellular face
21. Regulation of human T lymphocyte coactivation with an alpha4 integrin antagonist peptide
22. Alpha4 integrin binding interfaces on VCAM-1 and MAdCAM-1: Integrin binding footprints identify accessory binding sites that play a role in integrin specificity
23. Critical residues for ligand binding in an I domain-like structure of the integrin betal subunit
24. Molecular mapping of functional antibody binding sites of alpha 4 integrin
25. Folding of the N-terminal, ligand-binding region of integrin alpha-subunits into a beta-propeller domain
26. A structure prediction for the ligand-binding region of the integrin beta subunit: Evidence for the presence of a von Willebrand factor A domain
27. A secondary structure model of the integrin alpha subunit N-terminal domain based on analysis of multiple alignments
28. A cyclic hexapeptide is a potent antagonist of alpha 4 integrins
29. The crystal structure of an N-terminal two-domain fragment of vascular cell adhesion molecule 1 (VCAM-1): A cyclic peptide based on the domain 1 C-D loop can inhibit VCAM-1-alpha 4 integrin interaction
30. Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin
31. Database resources of the National Center for Biotechnology Information